These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17302281)

  • 21. [Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
    Larisch R; Klimke A
    Nuklearmedizin; 1998; 37(7):245-50. PubMed ID: 9830615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography in schizophrenia: a new perspective.
    Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A
    J Nucl Med; 2010 Apr; 51(4):511-20. PubMed ID: 20237027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging as tool to investigate psychoses and antipsychotics.
    Booij J; van Amelsvoort T
    Handb Exp Pharmacol; 2012; (212):299-337. PubMed ID: 23129337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies.
    Takano H
    Front Psychiatry; 2018; 9():228. PubMed ID: 29896132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain imaging research: does the science serve clinical practice?
    Wong DF; Gründer G; Brasic JR
    Int Rev Psychiatry; 2007 Oct; 19(5):541-58. PubMed ID: 17896234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
    Hall H; Sedvall G; Magnusson O; Kopp J; Halldin C; Farde L
    Neuropsychopharmacology; 1994 Dec; 11(4):245-56. PubMed ID: 7531978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride.
    Takano A; Suhara T; Yasuno F; Suzuki K; Takahashi H; Morimoto T; Lee YJ; Kusuhara H; Sugiyama Y; Okubo Y
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):539-45. PubMed ID: 16288681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors--the present state of research and perspectives.
    Wolfarth S; Ossowska K
    Pol J Pharmacol; 1995; 47(3):207-18. PubMed ID: 8714754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
    Vasdev N; Natesan S; Galineau L; Garcia A; Stableford WT; McCormick P; Seeman P; Houle S; Wilson AA
    Synapse; 2006 Sep; 60(4):314-8. PubMed ID: 16786538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular imaging in the drug development of psychotropics using positron emission tomography].
    Takano H; Takahashi H; Ito H; Suhara T
    Brain Nerve; 2007 Mar; 59(3):215-20. PubMed ID: 17370647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.
    Vernaleken I; Siessmeier T; Buchholz HG; Härtter S; Hiemke C; Stoeter P; Rösch F; Bartenstein P; Gründer G
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):421-30. PubMed ID: 15683553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S; Zipursky R; Jones C; Remington G; Houle S
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.